Ovarian Cancer Research Alliance (OCRA) is the largest global organization in the fight against ovarian and other gynecologic cancers, driving progress through innovative research, comprehensive support programs, and advocacy. Since 1994, OCRA has invested $140 million in scientific breakthroughs, supports more than 110,000 individuals annually, and—as the only organization solely dedicated to advancing ovarian and gynecologic cancer priorities on Capitol Hill—has helped secure $3.8 billion in federal funding.